Flossy is a technology company.
Flossy has raised $22.0M across 3 funding rounds.
Flossy has raised $22.0M in total across 3 funding rounds.
Flossy is a dental technology company building an AI-based platform to streamline dental care delivery for practitioners, patients, and payors.[1] It offers AI dental receptionists, virtual consultations, and custom prescription oral care solutions addressing issues like cavities and sensitivity, making care more accessible and affordable.[1][2] Headquartered in New York with roots in California, Flossy targets the fragmented dental industry by reducing phone tag, simplifying appointments, and enabling efficient diagnosis and treatment.[1][2][4]
The company serves dental practices and patients seeking painless, tech-enabled experiences, solving pain points like confusing dentist discovery and multi-visit requirements.[1] Its growth leverages rapid AI adoption in healthcare, positioning it as an affordable, customer-first partner for industry leaders.[1]
Flossy was founded in 2019 by Miles and Steve, serial health-tech entrepreneurs with decades of experience in medicine and technology.[1][2] After selling their previous business, both founders independently encountered frustrating dental appointment processes—days of phone tag and disjointed visits—sparking their obsession with dental innovation.[1]
They assembled a dedicated team of longtime collaborators to create an all-in-one AI dental solutions platform.[1] Pivotal early traction stemmed from applying their expertise to real-world pain points, evolving from personal frustration into a comprehensive offering amid AI's rise in healthcare.[1][2]
Flossy's edge lies in its AI-driven tools tailored for dental workflows:
These features create seamless developer and user experiences, fostering long-term partnerships in a transforming dental ecosystem.[1]
Flossy rides the AI transformation in dental care, a subset of health-tech where automation addresses chronic inefficiencies like staffing shortages and patient no-shows.[1] Timing is ideal as AI maturity (post-2019 founding) aligns with post-pandemic demand for virtual, accessible healthcare, amplified by market forces like rising oral care needs and telehealth adoption.[1][2]
It influences the ecosystem by empowering practices with scalable tools, reducing administrative burdens, and enabling growth for top dental businesses—potentially setting standards for AI in specialized medicine.[1] This positions Flossy amid tailwinds from investor interest in vertical AI SaaS, bridging consumer-facing tele-dentistry with B2B operations.[2][4]
Flossy is primed to expand as the AI dental leader, scaling its platform with new agents for diagnostics, billing, and personalized treatments amid accelerating health AI investments.[1] Trends like multimodal AI and regulatory tailwinds for telehealth will shape its path, potentially capturing share in a $150B+ U.S. dental market.
Its influence may evolve toward ecosystem dominance, integrating with EHR systems and payors, while founder expertise drives acquisitions or IPO trajectories—reinforcing its mission to make dental care effortlessly innovative.[1]
Flossy has raised $22.0M in total across 3 funding rounds.
Flossy's investors include Curie.Bio, Jenny Fielding, Scott Hartley, FabFitFun, TTV Capital, Addition, John Lyman, Operator Partners, Tusk Venture Partners.
Flossy has raised $22.0M across 3 funding rounds. Most recently, it raised $4.0M Venture Round in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $4.0M Venture Round | Curie.Bio, Jenny Fielding, Scott Hartley, FabFitFun, TTV Capital | |
| Aug 1, 2022 | $15.0M Series A | Curie.Bio, Jenny Fielding, Scott Hartley, FabFitFun, TTV Capital | |
| Mar 1, 2020 | $3.0M Seed | Addition, Curie.Bio, Jenny Fielding, Scott Hartley, FabFitFun, John Lyman, Operator Partners, TTV Capital, Tusk Venture Partners |